Key result
TMPFC independently predicts 30-day and 6-month MACE in patients undergoing primary angioplasty.
Why the study?
Currently available methods for assessing myocardial perfusion, including TIMI myocardial perfusion grading and myocardial blush grading, are subjective and lack quantitative precision.
Does TIMI Myocardial Perfusion Frame Count (TMPFC) accurately quantify myocardial perfusion and predict short-term MACE in patients undergoing primary angioplasty?
Observational (n=152)
Does TIMI Myocardial Perfusion Frame Count (TMPFC) accurately quantify myocardial perfusion and predict short-term MACE in patients undergoing primary angioplasty?
p-value: p=0.0261 (30-day) and 0.0207 (6-month)
TMPFC provides an objective, quantitative assessment of myocardial perfusion that independently predicts short-term MACE following primary angioplasty.
TMPFC offers objective perfusion quantification in angiography; extends subjective methods yet leaves open outcome validation before adoption.
Objectives: We sought to develop a new quantitative method to evaluate the degree of myocardial perfusion. Background: Currently available methods for assessing myocardial perfusion, both TIMI myocardial perfusion grading (TMPG) and myocardial blush grading (MBG), are subjective. Methods: TIMI Myocardial Perfusion Frame Count (TMPFC), an objective method that measures the filling and clearance of contrast in the myocardium using cine‐angiographic frame‐counting, was developed to quantify myocardial perfusion. Myocardial perfusion of 45 normal coronary arteries in 15 patients, and 137 culprit arteries in 137 patients immediately after primary angioplasty, was successfully assessed with TMPFC. Results: The mean TMPFC in the normal arteries was 83.47 ± 17.96 frames (95% CI: 78.07 frames ≤ TMPFC ≤ 88.86 frames). Therefore, TMPFC < 90 frames, a value representing the upper bound of the 95% CI for the TMPFC observed in normal arteries, was defined as normal myocardial perfusion. In 137 culprit arteries, the mean TMPFC values after primary angioplasty for the right coronary artery (RCA), left anterior descending artery (LAD), and left circumflex artery (LCX) were 141 ± 82.6, 112 ± 80.3, and 102 ± 37.5 frames, respectively. Patients with suboptimal myocardial perfusion (ex: TMPG ≤ 2 or MBG ≤ 2 grade) had higher levels of TMPFC. Furthermore, multivariate analysis shows that the TMPFC was an independent predictor for 30‐day (P = 0.0261) and 6‐month incidence of MACE (P = 0.0207). Conclusions: TMPFC is a quantitative index for the assessment of myocardial perfusion; it allows quantification of TMPG and may serve as a discerning tool to predict prognosis in patients undergoing primary angioplasty.
No takes yet. Share an insight, caveat, or question.
Ding et al. (2009) conducted an observational in Myocardial perfusion post-primary angioplasty (n=152). TIMI Myocardial Perfusion Frame Count (TMPFC) was evaluated on 30-day and 6-month incidence of MACE (p=0.0261 (30-day) and 0.0207 (6-month)). TIMI Myocardial Perfusion Frame Count (TMPFC) served as an independent predictor for the 30-day (P=0.0261) and 6-month (P=0.0207) incidence of MACE in patients undergoing primary angioplasty.
Synapse has enriched 4 closely related papers on similar clinical questions. Consider them for comparative context: